Trial Planned of Retinal Tracer in Detecting ALS via Eye Exam

Trial Planned of Retinal Tracer in Detecting ALS via Eye Exam

314919

Trial Planned of Retinal Tracer in Detecting ALS via Eye Exam

Amydis announced plans to launch a first clinical trial next year into the ability of its small molecule tracer to detect toxic TDP-43 clumps — a hallmark of amyotrophic lateral sclerosis (ALS) — in the eye’s retina. Its announcement follows a preliminary meeting with U.S. Food and Drug Administration (FDA) officials, at which the agency agreed with the overall design of the proposed Phase 1/2a study, intended to test if the tracer might aid in diagnosing and…

You must be logged in to read/download the full post.